Article Information
History
- December 2, 2020.
Article Versions
- You are currently viewing Version 1 of this article (December 2, 2020 - 15:20).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Inesa Thomsen1,
- Natalia Kunowska1,
- Roshni de Souza1,
- Anne-Marie Moody1,
- Greg Crawford2,
- Yi-Fang Wang3,
- Sanjay Khadayate3,
- Jessica Strid2,
- Mohammad M. Karimi3,4,
- Alexis Barr5,6,
- Niall Dillon1,* and
- Pierangela Sabbattini1
- 1Gene Regulation and Chromatin Group, MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK.
- 2Department of Immunology and Inflammation, Imperial College London, Hammersmith Hospital Campus, Du Cane London W12 0NN, UK.
- 3Bioinformatics and Computing, MRC London Institute of Medical Sciences, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK.
- 4Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King’s College London, London SE5 8AF, UK
- 5Cell Cycle Control Group, MRC London Institute of Medical Sciences, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK.
- 6Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK.
- ↵*Correspondence to niall.dillon{at}lms.mrc.ac.uk
Posted December 02, 2020.
RUNX1 controls the dynamics of cell cycle entry of naïve resting B cells by regulating expression of cell cycle and immunomodulatory genes in response to BCR stimulation
